News | May 05, 2022
Promising new universal coronavirus vaccine candidate discovered
Formula attenuates 99% of 365 coronaviruses in computer models
Formula attenuates 99% of 365 coronaviruses in computer models
In the UK, Bartec has been synonymous with Mediso products for 18 years, proof of a successful partnership
At an affordable price, a researcher can process fresh samples of 10,000 cells immediately with a stable stopping point within two hours, simplifying sample management at the laboratory and limiting transcriptional changes
Three RFPs now open for qualified researchers through NORD's Jayne Holtzer rare disease research grants program
The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases
Onshore manufacturing facility is expected to be based in Quebec and produce up to 100 million mRNA respiratory vaccine doses annually
Move brings together AstraZeneca and Alexion colleagues in a purpose-built facility in Kendall Square, Cambridge, MA, a world-leading life sciences hub
Cysoni is a bionic device that paces the heart with real-time respiratory modulation
Danish National Genome Center partners with Lifebit to deliver nationwide personalised medicine
It includes multiple studies demonstrating that post-translational modifications of conformational variants of p53 are associated with the pathogenesis of Alzheimer's Disease
Subscribe To Our Newsletter & Stay Updated
